Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer's disease: a prospective cohort study-Reference-Cited by-同舟云学术

Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer's disease: a prospective cohort study

Published:2015-08 Issue:8 Volume:14 Page:804-813
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Yau Wai-Ying Wendy,Tudorascu Dana L,McDade Eric M,Ikonomovic Snezana,James Jeffrey A,Minhas Davneet,Mowrey Wenzhu,Sheu Lei K,Snitz Beth E,Weissfeld Lisa,Gianaros Peter J,Aizenstein Howard J,Price Julie C,Mathis Chester A,Lopez Oscar L,Klunk William E

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Clinical Neurology

Reference35 articles.

1. 2014 Alzheimer's disease facts and figures;Alzheimers Dement,2014

2. Testing the right target and right drug at the right stage;Sperling;Sci Transl Med,2011

3. Clinical and biomarker changes in dominantly inherited Alzheimer's disease;Bateman;N Engl J Med,2012

4. Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease;Benzinger;Proc Natl Acad Sci USA,2013

5. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study;Villemagne;Lancet Neurol,2013

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 15 Years of Longitudinal Genetic, Clinical, Cognitive, Imaging, and Biochemical Measures in DIAN;2024-08-09

2. Amyloid‐β in Alzheimer's disease: Structure, toxicity, distribution, treatment, and prospects;Ibrain;2024-05-23

3. Basal forebrain volume and metabolism in carriers of the Colombian mutation for autosomal dominant Alzheimer’s disease;Scientific Reports;2024-05-17

4. HumanAPOEallelic variants suppress the formation of diffuse and fibrillar Aβ deposits relative to mouseApoein transgenic mouse models of Alzheimer amyloidosis;2024-05-01

5. Biomarker Changes during 20 Years Preceding Alzheimer’s Disease;New England Journal of Medicine;2024-02-22